A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
首个亮氨酰-tRNA合成酶抑制剂ganfeborole用于治疗利福平敏感结核病:一项2a期开放标签随机试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-02829-7
Diacon, Andreas H; Barry, Clifton E 3rd; Carlton, Alex; Chen, Ray Y; Davies, Matt; de Jager, Veronique; Fletcher, Kim; Koh, Gavin C K W; Kontsevaya, Irina; Heyckendorf, Jan; Lange, Christoph; Reimann, Maja; Penman, Sophie L; Scott, Rhona; Maher-Edwards, Gareth; Tiberi, Simon; Vlasakakis, Georgios; Upton, Caryn M; Aguirre, David Barros